2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow Cutaneous Lupus: new trials by email Literature Review of Cutaneous Lupus trials Research Report on Cutaneous Lupus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Relevance of Monitoring Blood and Salivar Levels of Drugs Used in Rheumatic Autoimmune Diseases Thalidomide, Hydroxychloroquine reduced, standard dose of HCQ - Systemic Lupus Erythematosus (SLE), Juvenile SLE | Phase 4 | Completed | University of Sao Paulo General Hospital | 93 | 2017-06-05 | 2021-12-16 |
| Study To Evaluate The Safety And Efficacy Of Lenalidomide For Refractory Cutaneous Lupus Lenalidomide - Cutaneous Lupus | Phase 4 | Completed | Hospital Universitari Vall d'Hebron Research Institute | 15 | 2010-01-01 | 2011-08-03 |
Lupus Erythematosus, Systemic (1)
Autoimmune Diseases (1) · Connective Tissue Diseases (1) · Immune System Diseases (1) · Skin and Connective Tissue Diseases (1)
Hydroxychloroquine (1) · Lenalidomide (1) · Thalidomide (1)
Hospital Universitari Vall d'Hebron Research Institute (1) · University of Sao Paulo General Hospital (1)
Brazil (1) · Spain (1)
2009 (1)